Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Reporter.
Press releases published on April 22, 2025

Telix Reports US$186M Q1 Revenue, Up 62% YOY
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 ( …

Ekosystém Bitget v 1. čtvrtletí získal 20 milionů nových uživatelů a zaznamenal 159% nárůst spotového trhu na platformě
VICTORIA, Seychely, April 22, 2025 (GLOBE NEWSWIRE) -- Bitget, přední kryptoměnová burza a společnost zaměřená na Web3, zakončila první čtvrtletí roku 2025 s celkovým objemem obchodů ve výši 2,08 bilionu USD, a to díky prudkému, 159% nárůstu spotových …

Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”), a biotechnology company specializing cosmetic ingredients and new drug discoveries, is pleased to announce the successful …

Integral Metals Welcomes Shervin Pishevar as an Advisor to the Company
CALGARY, Alberta, April 22, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the addition of Shervin Pishevar as an Advisor to the Company. With his extensive experience …

HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
HONG KONG and FLORHAM PARK, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has completed enrollment of the registration phase of its Phase II trial of savolitinib in …

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice from the NYSE …